MA52936A - Composés inhibiteurs d'oga - Google Patents

Composés inhibiteurs d'oga

Info

Publication number
MA52936A
MA52936A MA052936A MA52936A MA52936A MA 52936 A MA52936 A MA 52936A MA 052936 A MA052936 A MA 052936A MA 52936 A MA52936 A MA 52936A MA 52936 A MA52936 A MA 52936A
Authority
MA
Morocco
Prior art keywords
inhibitor compounds
oga inhibitor
oga
compounds
inhibitor
Prior art date
Application number
MA052936A
Other languages
English (en)
Inventor
José Manuel Bartolomé-Nebreda
Susana Conde-Ceide
Lucas Olivares Ana Isabel De
Andrés Avelino Trabanco-Suárez
Gary John Tresadern
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MA52936A publication Critical patent/MA52936A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
MA052936A 2018-06-20 2019-06-20 Composés inhibiteurs d'oga MA52936A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18382448 2018-06-20

Publications (1)

Publication Number Publication Date
MA52936A true MA52936A (fr) 2021-04-28

Family

ID=62784075

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052936A MA52936A (fr) 2018-06-20 2019-06-20 Composés inhibiteurs d'oga

Country Status (8)

Country Link
US (1) US20210115040A1 (fr)
EP (1) EP3810136A1 (fr)
JP (1) JP2021527662A (fr)
CN (1) CN112312908A (fr)
AU (1) AU2019289969A1 (fr)
CA (1) CA3103047A1 (fr)
MA (1) MA52936A (fr)
WO (1) WO2019243528A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020509004A (ja) * 2017-02-27 2020-03-26 ヤンセン ファーマシューティカ エヌ.ベー. Oga阻害剤としての、ピペリジン、モルホリンまたはピペラジンで置換されている[1,2,4]−トリアゾロ[1,5−a]−ピリミジニル誘導体
WO2021094312A1 (fr) * 2019-11-11 2021-05-20 Janssen Pharmaceutica Nv Composés inhibiteurs d'oga contenant de la pyrrolidine et de la bicyclohétéroaryle

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9243020B2 (en) * 2010-12-23 2016-01-26 Alectos Therapeutics Inc. Selective glycosidase inhibitors and uses thereof
JP2015531401A (ja) * 2011-10-10 2015-11-02 ハー・ルンドベック・アクチエゼルスカベット イミダゾピラジノン骨格を有するpde9i
WO2016030443A1 (fr) * 2014-08-28 2016-03-03 Asceneuron Sa Inhibiteurs de glycosidases

Also Published As

Publication number Publication date
US20210115040A1 (en) 2021-04-22
WO2019243528A1 (fr) 2019-12-26
AU2019289969A1 (en) 2020-12-17
JP2021527662A (ja) 2021-10-14
CA3103047A1 (fr) 2019-12-26
EP3810136A1 (fr) 2021-04-28
CN112312908A (zh) 2021-02-02

Similar Documents

Publication Publication Date Title
MA52942A (fr) Composés inhibiteurs d'oga
MA52939A (fr) Composés inhibiteurs d'oga
MA47575A (fr) Composés inhibiteurs d'oga monocyclique
MA47576A (fr) Composés inhibiteurs d'oga bicyclique
MA47420A (fr) Composés inhibiteurs d'oga
MA52486A (fr) Pyridazinones utilisés en tant qu'inhibiteurs de parp7
MA52489A (fr) Nouveaux composés
MA52948A (fr) Composés
MA44725A (fr) Formulations d'un inhibiteur de lsd1
MA52967A (fr) Composés antagonistes du pcsk9
MA51669A (fr) Composés
MA51616A (fr) Inhibiteurs d'adn-pk
MA52004A (fr) Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glycopyranosidase
DK3687994T3 (da) Gadolinium-bærende pcta-baserede kontrastmidler
MA53003A (fr) Composés
UA42295S (uk) Комп'ютер
MA46652A (fr) Polythérapie pour l'inhibition de c3
MA54521A (fr) Dérivés d'oxopyridine substitués
MA46242A (fr) Composés inhibiteurs de bêta-lactamase
DK3762368T3 (da) Aminopyrazindiolforbindelser som pi3k-y-inhibitorer
MA49006A (fr) Inhibiteurs d'ip6k
DK3737677T3 (da) Tetrahydroisoquinolinforbindelser
UA42369S (uk) Комп'ютер
MA52946A (fr) Composés
MA53430A (fr) Nouveaux composés